✦ LIBER ✦

PPARγ agonists and coronary atherosclerosis

✍ Scribed by Melanie S. Sulistio; Adrienne Zion; Nandish Thukral; Robert Chilton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PPAR-γ agonists and diabetic nephropathy

✍ Yahua Zhang; Youfei Guan 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 603 KB

Atherosclerosis and cardiovascular risk

✍ Johanna Kuusisto; Laura Andrulionyte; Markku Laakso 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 156 KB

PPAR agonists in the treatment of athero

✍ Gordon A Francis; Jean-Sébastien Annicotte; Johan Auwerx 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

PPAR-α and PPAR-γ agonists for type 2 di

✍ Bernard Charbonnel 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 266 KB

PPARγ agonists for intestinal ischaemia

✍ N Matsuhashi; K Watanabe; H Kanamori; S Ohnishi; M Omata 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 60 KB

Evaluation of anti-atherosclerotic activ

✍ Rai Ajit K. Srivastava 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 376 KB